# Maxion Therapeutics: Biotechnology, Cambridge, United Kingdom

> Maxion Therapeutics: Maxion Therapeutics is a private biotechnology company based in Cambridge, United Kingdom, founded in 2020.

Source: https://millionrounds.com/startup/maxion-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# Maxion Therapeutics

Maxion Therapeutics is a private biotechnology company based in Cambridge, United Kingdom, founded in 2020.

Funding reported Last round: Grant

Biotechnology Cambridge, United Kingdom

Company summary

- **Founded:** 2020 6 years old
- **Team:** 58 51 to 200 people
- **Funding reported:** 75.3M as listed, currency not stated
- **Last round:** Grant Apr 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Maxion Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Maxion Therapeutics

Maxion Therapeutics is a private biotechnology company based in Cambridge, United Kingdom, founded in 2020.

It specializes in drug discovery, clinical trials, and precision medicine, focusing on developing innovative therapeutics for chronic pain, autoimmune disorders, and cardiovascular diseases. The company is led by a team of experienced professionals with strong backgrounds in the pharmaceutical industry. The cornerstone of Maxion's innovation is its proprietary KnotBody® technology, which combines naturally occurring mini-proteins called knottins with antibodies. This hybrid approach allows for the development of therapeutics that effectively target ion channels and G-protein-coupled receptors, addressing conditions that are difficult to treat with traditional methods. Maxion is currently in the late-stage R&D phase, having raised approximately $90.5 million, including a significant Series A round of $72 million. The company is expanding its research and development capabilities to accelerate its drug development pipeline.

## What company datasets say Maxion Therapeutics raised

Funding, as reported

Reported in all **75.3M** in the source's currency

Rounds **2**

Last round **Grant**

Last round size **76.6M**

Last round date **Apr 2023**

Investors listed **5**

## Funding filed with regulators

Maxion Therapeutics filed 3 raises, $91M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Mar 2025 **$75M** UK share allotment
- Feb 2023 **$16M** UK share allotment
- Feb 2023 **$185K** UK share allotment

## Founders and team

From Maxion Therapeutics's own website: 4 on the team.

- **Dr Sohaib Mir** Non-Executive Director
- **Dr Tim Funnell** Non-Executive Director
- **Elena Viboch** Non-Executive Director
- **Eva-Lotta Allan** Independent Chair

## On 2 portfolio pages

Investors who name them

- [Solasta Ventures](https://millionrounds.com/fund/solasta-ventures)
- [LifeArc Ventures](https://millionrounds.com/fund/lifearc-ventures)

Each firm lists Maxion Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care manufacturing medical research phage display autoimmune disease treatment biotech research drug development platform protein drug discovery knottins hospital & health care medical health biotechnology mechanical or industrial engineering ion channel targeting research and development in the physical

Built with from their website

Amazon CloudFront ANS YouTube CloudFlare Gem Viewport Meta Alia nordpass Webflow Hosting CloudFlare CDN

+8 more

Google Font API Microsoft Exchange Microsoft 365 Apps & Services BambooHR Mobile Friendly Shopify Open Graph jQuery

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 2834, 2836
- **Region:** England
- **Revenue:** 2.1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/maxion-therapeutics)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**PhoreMost Ltd** Cambridge · founded 2014](https://millionrounds.com/startup/phoremost-ltd)

## Is this your company?

Add your raise, your deck and your story, and put Maxion Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)